Global Tumor Ablation Market Set to Reach USD 1.4 Billion by 2029
The global tumor ablation market, valued at US$0.7 billion in 2023, stood at US$0.8 billion in 2024 and is projected to advance at a resilient CAGR of 10.0% from 2024 to 2029, culminating in a forecasted valuation of US$1.4 billion by the end of the period. The global tumor ablation market is entering a decisive growth phase as healthcare systems worldwide prioritize minimally invasive cancer treatments amid a rising global cancer burden.
This news release from MarketsandMarkets highlights the growth of the global tumor ablation market, which is expected to reach USD 1.4 billion by 2029. The market is driven by advancements in ablation technologies, increasing healthcare access in emerging economies, and strategic investments by medtech leaders. Key factors include the rising incidence of cancer, especially among the geriatric population, and the preference for minimally invasive treatments. Technological advancements in probes, electrodes, and generator systems are improving procedural accuracy and minimizing damage to healthy tissue. Despite challenges such as high capital costs, opportunities in emerging markets and government initiatives to improve healthcare access are expected to drive growth.
0 Comments